Neuralgia. Trigeminal neuralgia
Conditions
Interventions
Intervention 1: Intervention group: Treatment will start with 100 mg of carbamazepine and add 100 mg to the dose once every three days (depending on the patient's pain intensity). This process contin
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients whose definitive diagnosis of trigeminal neuralgia is based on the IHS (International Headache Society) People who are seeing a doctor for the first time for treatment or have received standard medication but have had no effect on their recovery. Idiopathic disease (such as vascular malformations, brain tumors, or diseases such as multiple sclerosis that cause the disease).
Exclusion criteria
Exclusion criteria: Pregnancy Blood problem liver functional problem Dissatisfaction to contribute in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: pain score at the beginning of the study (before the intervention) and immediately after each session of laser therapy and one month after the intervention. Method of measurement: VISUAL ANALOG SCALE. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of pain relief. Timepoint: At the end of study. Method of measurement: checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Davodi
Arak University of Medical Sciences
Outcome results
None listed